Bendamustine associated immune suppression and infections during therapy of hematological malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bendamustine associated immune suppression and infections during therapy of hematological malignancies

Published:2015-12-23 Issue:3 Volume:57 Page:512-519
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Gafter-Gvili Anat¹²,Polliack Aaron³

Affiliation:

1. Department of Medicine A, Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel;

2. Sackler School of Medicine, Tel-Aviv, Israel;

3. Department of Hematology, Hadassah University Hospital and Hebrew University Medical School, Ein Karem, Jerusalem, Israel

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1110748

Reference58 articles.

1. Pharmacokinetic evaluation and therapeutic activity of bendamustine in B-cell lymphoid malignancies

2. Bendamustine: Safety and Efficacy in the Management of Indolent Non-Hodgkins Lymphoma

3. Bendamustine (Treanda) Displays a Distinct Pattern of Cytotoxicity and Unique Mechanistic Features Compared with Other Alkylating Agents

4. Optimal Use of Bendamustine in Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphomas, and Multiple Myeloma: Treatment Recommendations From an International Consensus Panel

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empfehlung für Leukozytapheresen zur CAR-T-Zell-Herstellung;Transfusionsmedizin;2024-08

2. Efficacy and safety of bendamustine‐containing bridging therapy in R/R LBCL patients receiving CD19 CAR T‐cells;HemaSphere;2024-06-26

3. T-cell help in the tumor microenvironment enhances rituximab-mediated NK-cell ADCC;Blood;2024-05-02

4. Signal detection of adverse reactions for bendamustine based on FDA adverse event reporting system;Expert Opinion on Drug Safety;2024-04-30

5. Disseminated Enterovirus Infection in a Patient Affected by Follicular Lymphoma Treated with Obinutuzumab: A Case Report and a Narrative Review of the Literature;Medicina;2024-03-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3